Instrument Inactif

Autres langues Insite Vision Inc.

Actions

INSV

US4576601086

Produits pharmaceutiques

Cours en clôture OTC Bulletin Board
- ^USD	-

02/02/15	Insite Vision : Nicox en hausse après un accord avec Site Vision	RE
02/02/15	Insite Vision : Nicox-Accord de licence avec InSite Vision en Europe	RE

Autres langues

15/09/15	InSite Vision : and Sun Pharma Enter into Merger Agreement
03/09/15	InSite Vision : Receives Second Unsolicited Acquisition Proposal for $0.35 per Share From a Global Pharmaceutical Company
03/09/15	InSite Vision : Announces New Date for Special Stockholder Meeting
02/09/15	InSite Vision : Named in BromSite Patent Lawsuit; Company Believes Lawsuit Is Without Merit
21/08/15	InSite Vision : Determines that an Unsolicited Offer from a Multi-National Pharmaceutical Company to Acquire InSite for $0.25 in Cash Constitutes a “Company Superior Proposal”
17/08/15	InSite Vision : Announces FDA Acceptance of NDA Filing for BromSite™ (0.075% bromfenac)
12/08/15	InSite Vision : Announces Date for Special Stockholder Meeting
11/08/15	Insite Vision : Reports Second Quarter 2015 Financial Results
10/08/15	InSite Vision : Receives Unsolicited Proposal from a Multi-National Pharmaceutical Company
11/06/15	InSite Vision : Announces Completion of the New Drug Application Submission to the U.S. FDA for BromSite
12/05/15	InSite Vision : Reports First Quarter 2015 Financial Results
07/05/15	InSite Vision : to Report First Quarter 2015 Results on May 14, 2015
17/03/15	InSite Vision : Announces Settlement of Patent Infringement Lawsuit Against Mylan Pharmaceutical, Inc.
17/02/15	InSite Vision : to Report Fourth Quarter and Year-End 2014 Results on February 17, 2015
17/02/15	InSite Vision : Reports Fourth Quarter and Year-End 2014 Financial Results
10/02/15	InSite Vision : to Report Fourth Quarter and Year-End 2014 Results on February 17, 2015
02/02/15	InSite Vision : Announces License Agreement for AzaSite®, AzaSite Xtra™ and BromSite™ in Europe, Middle East and Africa
19/12/14	InSite Vision : Announces Date for Annual Stockholder Meeting
05/11/14	InSite Vision : Reports Third Quarter 2014 Financial Results
29/10/14	InSite Vision : to Report Third Quarter 2014 Financial Results on November 5, 2014
13/08/14	InSite Vision : Reports Second Quarter 2014 Financial Results
05/08/14	InSite Vision : to Report Second Quarter 2014 Financial Results on August 13, 2014
16/07/14	InSite Vision : Announces the Issuance of Broad U.S. Patent Covering Bromfenac Formulations in DuraSite®
15/07/14	InSite Vision : to Webcast Annual Meeting of Stockholders on July 16, 2014
08/07/14	InSite Vision : Plans to Submit New Drug Application to FDA for DexaSite™ for the Treatment of Blepharitis in Adults